Skip to main content
Figure 3 | BMC Musculoskeletal Disorders

Figure 3

From: Effective osteoporosis treatment with teriparatide is associated with enhanced quality of life in postmenopausal women with osteoporosis: the European Forsteo Observational Study

Figure 3

Extreme problems in EQ-5D domains. Patients (%) reporting extreme problems at baseline and at 18- and 36-months follow-up in the five domains of EQ-5D for (a) the total study cohort, (b) group A with recent prior fracture and incident fracture; (c) group B with recent prior fracture and no incident fracture; (d) group C with no recent prior fracture and incident fracture; and (e) group D with no recent prior fracture and no incident fracture. The remaining patients in each group reported either no problems or some problems for each domain.

Back to article page